TCL Archive Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival July 27, 2012
TCL Archive Study Attributes Drop In Breast Cancer Incidence To Decline In Hormone Replacement. December 15, 2006